Hindustan Labs has taken a significant step toward entering the capital markets by submitting its draft red herring prospectus to the Securities and Exchange Board of India. The proposed initial public offering marks a pivotal moment in the company’s growth strategy, aimed at strengthening its balance sheet, funding expansion and enhancing brand visibility. The move comes amid steady investor interest in healthcare and diagnostic services, a sector driven by rising healthcare awareness and increased testing demand.